Aprepitant Versus Dexamethasone for Delayed Emesis: What Is the Role of the 5-Hydroxytryptamine Type 3 Receptor Antagonist Palonosetron?
Journal of Clinical Oncology - United States
doi 10.1200/jco.2014.55.4352
Full Text
Open PDFAbstract
Available in full text
Date
July 10, 2014
Authors
Publisher
American Society of Clinical Oncology (ASCO)